Showing results (2051-2060 of 2,175) with videos related to
Sort By:
Pageof 218
JAMA Dermatology|November 27, 2024
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical TrialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.Journal of the American College of Cardiology|May 7, 2016
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER TrialPascal Vranckx, Harvey D White, Zhen Huang, et al.Respiratory Care|July 12, 2022
Pediatric Ventilation Liberation: Bundled Extubation Readiness and Analgosedation Pathways Decrease Mechanical Ventilation Duration and Benzodiazepine ExposureJeremy M Loberger, Kristen C Waddell, Priya Prabhakaran, et al.American Heart Journal|August 25, 2015
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome modelsPrateeti Khazanie, Gretchen M Heizer, Vic Hasselblad, et al.Circulation|October 12, 2000
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III TrialE J Topol, E M Ohman, P W Armstrong, et al.Circulation. Heart Failure|July 7, 2023
Background Medical Therapy and Clinical Outcomes From the VICTORIA TrialJustin A Ezekowitz, Ciaran J McMullan, Cynthia M Westerhout, et al.Journal of Cardiac Failure|August 30, 2025
Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk StratificationChristopher M O'Connor, Sarah Rathwell, Devan V Mehrotra, et al.American Heart Journal|September 21, 2015
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trialJose Carlos Nicolau, Deepak L Bhatt, Matthew T Roe, et al.American Heart Journal|April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndromeConnie N Hess, Robert M Clare, Megan L Neely, et al.Circulation. Cardiovascular Interventions|May 11, 2016
Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic SubstudyChristopher J Popma, Shi Sheng, Serge Korjian, et al.Pageof 218